Compile Data Set for Download or QSAR
Report error Found 131 Enz. Inhib. hit(s) with all data for entry = 10858
LigandPNGBDBM575109(US11459321, Example 48)
Affinity DataIC50: 195nMAssay Description:To assess their antiviral activity, some compounds were tested against human cytomegalovirus (HCMV) in vitro. Human MRCS cells were grown to confluen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2022
Entry Details
Go to US Patent

LigandPNGBDBM575064(US11459321, Example 16)
Affinity DataIC50: 200nMAssay Description:To assess their antiviral activity, some compounds were tested against human cytomegalovirus (HCMV) in vitro. Human MRCS cells were grown to confluen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2022
Entry Details
Go to US Patent

TargetNeuraminidase(Influenza A virus (strain A/Puerto Rico/8/1934 H1N...)
Evrys Bio

US Patent
LigandPNGBDBM575094(US11459321, Example 29)
Affinity DataIC50: 289nMAssay Description:To assess their antiviral activity, some compounds were tested against murine adapted human influenza (PR8) in vitro. Canine MDCK cells were grown to...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2022
Entry Details
Go to US Patent

LigandPNGBDBM575077(US11459321, Example 22)
Affinity DataIC50: 306nMAssay Description:To assess their antiviral activity, some compounds were tested against human cytomegalovirus (HCMV) in vitro. Human MRCS cells were grown to confluen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2022
Entry Details
Go to US Patent

LigandPNGBDBM575106(US11459321, Example 56)
Affinity DataIC50: 317nMAssay Description:To assess their antiviral activity, some compounds were tested against human cytomegalovirus (HCMV) in vitro. Human MRCS cells were grown to confluen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2022
Entry Details
Go to US Patent

LigandPNGBDBM575082(US11459321, Example 27)
Affinity DataIC50: 345nMAssay Description:To assess their antiviral activity, some compounds were tested against human cytomegalovirus (HCMV) in vitro. Human MRCS cells were grown to confluen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2022
Entry Details
Go to US Patent

LigandPNGBDBM575079(US11459321, Example 24)
Affinity DataIC50: 353nMAssay Description:To assess their antiviral activity, some compounds were tested against human cytomegalovirus (HCMV) in vitro. Human MRCS cells were grown to confluen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2022
Entry Details
Go to US Patent

LigandPNGBDBM575119(US11459321, Example 62)
Affinity DataIC50: 362nMAssay Description:To assess their antiviral activity, some compounds were tested against human cytomegalovirus (HCMV) in vitro. Human MRCS cells were grown to confluen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2022
Entry Details
Go to US Patent

LigandPNGBDBM575091(US11459321, Example 73)
Affinity DataIC50: 423nMAssay Description:To assess their antiviral activity, some compounds were tested against human cytomegalovirus (HCMV) in vitro. Human MRCS cells were grown to confluen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2022
Entry Details
Go to US Patent

LigandPNGBDBM575069(US11459321, Example 14)
Affinity DataIC50: 453nMAssay Description:To assess their antiviral activity, some compounds were tested against human cytomegalovirus (HCMV) in vitro. Human MRCS cells were grown to confluen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2022
Entry Details
Go to US Patent

LigandPNGBDBM575063(US11459321, Example 9)
Affinity DataIC50: 479nMAssay Description:To assess their antiviral activity, some compounds were tested against human cytomegalovirus (HCMV) in vitro. Human MRCS cells were grown to confluen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2022
Entry Details
Go to US Patent

LigandPNGBDBM575110(US11459321, Example 49)
Affinity DataIC50: 516nMAssay Description:To assess their antiviral activity, some compounds were tested against human cytomegalovirus (HCMV) in vitro. Human MRCS cells were grown to confluen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2022
Entry Details
Go to US Patent

LigandPNGBDBM575100(US11459321, Example 72)
Affinity DataIC50: 537nMAssay Description:To assess their antiviral activity, some compounds were tested against human cytomegalovirus (HCMV) in vitro. Human MRCS cells were grown to confluen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2022
Entry Details
Go to US Patent

LigandPNGBDBM575104(US11459321, Example 44)
Affinity DataIC50: 552nMAssay Description:To assess their antiviral activity, some compounds were tested against human cytomegalovirus (HCMV) in vitro. Human MRCS cells were grown to confluen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2022
Entry Details
Go to US Patent

LigandPNGBDBM575095(US11459321, Example 41)
Affinity DataIC50: 553nMAssay Description:To assess their antiviral activity, some compounds were tested against human cytomegalovirus (HCMV) in vitro. Human MRCS cells were grown to confluen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2022
Entry Details
Go to US Patent

LigandPNGBDBM575107(US11459321, Example 46)
Affinity DataIC50: 605nMAssay Description:To assess their antiviral activity, some compounds were tested against human cytomegalovirus (HCMV) in vitro. Human MRCS cells were grown to confluen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2022
Entry Details
Go to US Patent

LigandPNGBDBM575111(US11459321, Example 50)
Affinity DataIC50: 613nMAssay Description:To assess their antiviral activity, some compounds were tested against human cytomegalovirus (HCMV) in vitro. Human MRCS cells were grown to confluen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2022
Entry Details
Go to US Patent

LigandPNGBDBM575102(US11459321, Example 43)
Affinity DataIC50: 617nMAssay Description:To assess their antiviral activity, some compounds were tested against human cytomegalovirus (HCMV) in vitro. Human MRCS cells were grown to confluen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2022
Entry Details
Go to US Patent

LigandPNGBDBM575088(US11459321, Example 34)
Affinity DataIC50: 633nMAssay Description:To assess their antiviral activity, some compounds were tested against human cytomegalovirus (HCMV) in vitro. Human MRCS cells were grown to confluen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2022
Entry Details
Go to US Patent

LigandPNGBDBM575081(US11459321, Example 26)
Affinity DataIC50: 637nMAssay Description:To assess their antiviral activity, some compounds were tested against human cytomegalovirus (HCMV) in vitro. Human MRCS cells were grown to confluen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2022
Entry Details
Go to US Patent

TargetNeuraminidase(Influenza A virus (strain A/Puerto Rico/8/1934 H1N...)
Evrys Bio

US Patent
LigandPNGBDBM575124(US11459321, Example 64)
Affinity DataIC50: 639nMAssay Description:To assess their antiviral activity, some compounds were tested against murine adapted human influenza (PR8) in vitro. Canine MDCK cells were grown to...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2022
Entry Details
Go to US Patent

TargetNeuraminidase(Influenza A virus (strain A/Puerto Rico/8/1934 H1N...)
Evrys Bio

US Patent
LigandPNGBDBM575079(US11459321, Example 24)
Affinity DataIC50: 663nMAssay Description:To assess their antiviral activity, some compounds were tested against murine adapted human influenza (PR8) in vitro. Canine MDCK cells were grown to...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2022
Entry Details
Go to US Patent

LigandPNGBDBM575090(US11459321, Example 36)
Affinity DataIC50: 666nMAssay Description:To assess their antiviral activity, some compounds were tested against human cytomegalovirus (HCMV) in vitro. Human MRCS cells were grown to confluen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2022
Entry Details
Go to US Patent

TargetNeuraminidase(Influenza A virus (strain A/Puerto Rico/8/1934 H1N...)
Evrys Bio

US Patent
LigandPNGBDBM575070(US11459321, Example 17)
Affinity DataIC50: 672nMAssay Description:To assess their antiviral activity, some compounds were tested against murine adapted human influenza (PR8) in vitro. Canine MDCK cells were grown to...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2022
Entry Details
Go to US Patent

LigandPNGBDBM575078(US11459321, Example 23)
Affinity DataIC50: 707nMAssay Description:To assess their antiviral activity, some compounds were tested against human cytomegalovirus (HCMV) in vitro. Human MRCS cells were grown to confluen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2022
Entry Details
Go to US Patent

TargetNeuraminidase(Influenza A virus (strain A/Puerto Rico/8/1934 H1N...)
Evrys Bio

US Patent
LigandPNGBDBM575086(US11459321, Example 32)
Affinity DataIC50: 716nMAssay Description:To assess their antiviral activity, some compounds were tested against murine adapted human influenza (PR8) in vitro. Canine MDCK cells were grown to...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2022
Entry Details
Go to US Patent

LigandPNGBDBM575122(US11459321, Example 59)
Affinity DataIC50: 730nMAssay Description:To assess their antiviral activity, some compounds were tested against human cytomegalovirus (HCMV) in vitro. Human MRCS cells were grown to confluen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2022
Entry Details
Go to US Patent

LigandPNGBDBM575112(US11459321, Example 51)
Affinity DataIC50: 737nMAssay Description:To assess their antiviral activity, some compounds were tested against human cytomegalovirus (HCMV) in vitro. Human MRCS cells were grown to confluen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2022
Entry Details
Go to US Patent

LigandPNGBDBM575114(US11459321, Example 57)
Affinity DataIC50: 742nMAssay Description:To assess their antiviral activity, some compounds were tested against human cytomegalovirus (HCMV) in vitro. Human MRCS cells were grown to confluen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2022
Entry Details
Go to US Patent

LigandPNGBDBM575070(US11459321, Example 17)
Affinity DataIC50: 748nMAssay Description:To assess their antiviral activity, some compounds were tested against human cytomegalovirus (HCMV) in vitro. Human MRCS cells were grown to confluen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2022
Entry Details
Go to US Patent

LigandPNGBDBM574849(US11459321, Example 4)
Affinity DataIC50: 758nMAssay Description:To assess their antiviral activity, some compounds were tested against human cytomegalovirus (HCMV) in vitro. Human MRCS cells were grown to confluen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2022
Entry Details
Go to US Patent

LigandPNGBDBM575108(US11459321, Example 47)
Affinity DataIC50: 796nMAssay Description:To assess their antiviral activity, some compounds were tested against human cytomegalovirus (HCMV) in vitro. Human MRCS cells were grown to confluen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2022
Entry Details
Go to US Patent

LigandPNGBDBM575085(US11459321, Example 31)
Affinity DataIC50: 803nMAssay Description:To assess their antiviral activity, some compounds were tested against human cytomegalovirus (HCMV) in vitro. Human MRCS cells were grown to confluen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2022
Entry Details
Go to US Patent

LigandPNGBDBM574980(US11459321, Example 5)
Affinity DataIC50: 807nMAssay Description:To assess their antiviral activity, some compounds were tested against human cytomegalovirus (HCMV) in vitro. Human MRCS cells were grown to confluen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2022
Entry Details
Go to US Patent

LigandPNGBDBM575094(US11459321, Example 29)
Affinity DataIC50: 858nMAssay Description:To assess their antiviral activity, some compounds were tested against human cytomegalovirus (HCMV) in vitro. Human MRCS cells were grown to confluen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2022
Entry Details
Go to US Patent

LigandPNGBDBM575089(US11459321, Example 35)
Affinity DataIC50: 891nMAssay Description:To assess their antiviral activity, some compounds were tested against human cytomegalovirus (HCMV) in vitro. Human MRCS cells were grown to confluen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2022
Entry Details
Go to US Patent

LigandPNGBDBM575087(US11459321, Example 33)
Affinity DataIC50: 903nMAssay Description:To assess their antiviral activity, some compounds were tested against human cytomegalovirus (HCMV) in vitro. Human MRCS cells were grown to confluen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2022
Entry Details
Go to US Patent

LigandPNGBDBM575080(US11459321, Example 25)
Affinity DataIC50: 911nMAssay Description:To assess their antiviral activity, some compounds were tested against human cytomegalovirus (HCMV) in vitro. Human MRCS cells were grown to confluen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2022
Entry Details
Go to US Patent

LigandPNGBDBM575093(US11459321, Example 40)
Affinity DataIC50: 956nMAssay Description:To assess their antiviral activity, some compounds were tested against human cytomegalovirus (HCMV) in vitro. Human MRCS cells were grown to confluen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2022
Entry Details
Go to US Patent

LigandPNGBDBM575086(US11459321, Example 32)
Affinity DataIC50: 979nMAssay Description:To assess their antiviral activity, some compounds were tested against human cytomegalovirus (HCMV) in vitro. Human MRCS cells were grown to confluen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2022
Entry Details
Go to US Patent

TargetNeuraminidase(Influenza A virus (strain A/Puerto Rico/8/1934 H1N...)
Evrys Bio

US Patent
LigandPNGBDBM575095(US11459321, Example 41)
Affinity DataIC50: 982nMAssay Description:To assess their antiviral activity, some compounds were tested against murine adapted human influenza (PR8) in vitro. Canine MDCK cells were grown to...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2022
Entry Details
Go to US Patent

LigandPNGBDBM575068(US11459321, Example 13)
Affinity DataIC50: 1.06E+3nMAssay Description:To assess their antiviral activity, some compounds were tested against human cytomegalovirus (HCMV) in vitro. Human MRCS cells were grown to confluen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2022
Entry Details
Go to US Patent

LigandPNGBDBM575071(US11459321, Example 18)
Affinity DataIC50: 1.08E+3nMAssay Description:To assess their antiviral activity, some compounds were tested against human cytomegalovirus (HCMV) in vitro. Human MRCS cells were grown to confluen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2022
Entry Details
Go to US Patent

TargetNeuraminidase(Influenza A virus (strain A/Puerto Rico/8/1934 H1N...)
Evrys Bio

US Patent
LigandPNGBDBM575090(US11459321, Example 36)
Affinity DataIC50: 1.09E+3nMAssay Description:To assess their antiviral activity, some compounds were tested against murine adapted human influenza (PR8) in vitro. Canine MDCK cells were grown to...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2022
Entry Details
Go to US Patent

LigandPNGBDBM575117(US11459321, Example 54)
Affinity DataIC50: 1.10E+3nMAssay Description:To assess their antiviral activity, some compounds were tested against human cytomegalovirus (HCMV) in vitro. Human MRCS cells were grown to confluen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2022
Entry Details
Go to US Patent

LigandPNGBDBM575116(US11459321, Example 58)
Affinity DataIC50: 1.13E+3nMAssay Description:To assess their antiviral activity, some compounds were tested against human cytomegalovirus (HCMV) in vitro. Human MRCS cells were grown to confluen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2022
Entry Details
Go to US Patent

TargetNeuraminidase(Influenza A virus (strain A/Puerto Rico/8/1934 H1N...)
Evrys Bio

US Patent
LigandPNGBDBM575102(US11459321, Example 43)
Affinity DataIC50: 1.16E+3nMAssay Description:To assess their antiviral activity, some compounds were tested against murine adapted human influenza (PR8) in vitro. Canine MDCK cells were grown to...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2022
Entry Details
Go to US Patent

LigandPNGBDBM574850(US11459321, Example 2)
Affinity DataIC50: 1.17E+3nMAssay Description:To assess their antiviral activity, some compounds were tested against human cytomegalovirus (HCMV) in vitro. Human MRCS cells were grown to confluen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2022
Entry Details
Go to US Patent

LigandPNGBDBM575074(US11459321, Example 67)
Affinity DataIC50: 1.19E+3nMAssay Description:To assess their antiviral activity, some compounds were tested against human cytomegalovirus (HCMV) in vitro. Human MRCS cells were grown to confluen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2022
Entry Details
Go to US Patent

TargetNeuraminidase(Influenza A virus (strain A/Puerto Rico/8/1934 H1N...)
Evrys Bio

US Patent
LigandPNGBDBM575063(US11459321, Example 9)
Affinity DataIC50: 1.25E+3nMAssay Description:To assess their antiviral activity, some compounds were tested against murine adapted human influenza (PR8) in vitro. Canine MDCK cells were grown to...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2022
Entry Details
Go to US Patent

Displayed 1 to 50 (of 131 total ) | Next | Last >>
Jump to: